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Reply
We cordially appreciate the valuable comments from Dr. Schach-
ner and colleagues on our study (1) assessing the relationship
between cerebral atherosclerosis and post-coronary artery bypass
graft (CABG) stroke. Cerebral atherosclerosis was both an inde-
pendent risk factor for and the cause of a significant (45%)
proportion of post-CABG strokes (1). Thus, as rightfully noted by
Dr. Schachner and colleagues, awareness and careful management
may be mandatory for those patients with cerebral atherosclerosis
who are undergoing CABG.
Dr. Schachner and colleagues had 2 specific questions for us:
Was the perioperative management adapted in patients with (more
severe) cerebrovascular disease, and did (severe) atherosclerosis of
the aortic arch and/or the ascending aorta have an impact on
post-CABG strokes? With regard to the first question, we cur-
rently do not have a routine protocol for patients with cerebral
atherosclerosis. Rather, perioperative management was decided
and performed adequately according to the situation by attending
physicians, surgeons, and anesthesiologists who were alerted to the
result of pre-operative magnetic resonance angiography (MRA).
To the best of our knowledge, no large study has been conducted
on the relationship between a specific perioperative management
and the risk of post-CABG stroke in patients with (severe)
cerebral atherosclerosis. But we agree with Dr. Schachner and
colleagues on the issue that modifying strategies may be helpful in
reducing the risk of post-CABG stroke. A small study of 140
patients undergoing CABG revealed that a different surgical
strategy (off-pump CABG) helped to prevent post-CABG strokes
(2). In addition, different perioperative management (e.g., imme-
diate commencement of antiplatelet or anticoagulant therapy and
prolonged cardiac monitoring after the surgery in patients with
cerebral atherosclerosis) can be a useful strategy to reduce the
stroke risk. Additional studies are warranted to elucidate the
optimal management in those patients.
For the second question, all patients did not undergo aortic
evaluation by transesophageal echocardiography (TEE) in our
study. In addition, intraoperative epiaortic ultrasonography data
were not recorded in the study registry. Thus, we cannot provide rthe exact data regarding the question. But, we believe that severe
atherosclerosis of the aortic arch and/or the ascending aorta can
increase the risk of post-CABG stroke (3). Accordingly, in our
institution, surgeons tend to perform off-pump CABG and/or
aortic “no-touch” techniques in those with severe athermanous
aortic disease. Notably, current aorta-evaluating methods may be
too invasive to be applied to all CABG candidates. The elderly
cannot tolerate pre-operative TEE too often; embolic strokes can
be induced by direct manipulation of the aorta with unstable
atheroma. Thus, investigating noninvasive predictors of aortic
atherosclerosis may be useful. We believe that cerebral atheroscle-
rosis evaluated by using MRA can be one of those predictors. It
may be interesting to evaluate the relationship between aortic arch
and cerebral atherosclerosis by conducting both pre-operative TEE
and MRA in stable CABG patients. In addition, we believe that
this approach might bring us the right answer with regard to the
second question raised by Dr. Schachner and colleagues.
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Impaired Fasting Glucose
and the Risk of Incident
Diabetes Mellitus and
Cardiovascular Events
We read with great interest the paper by Yeboah et al. (1)
egarding the effect of impaired fasting glucose (IFG) and incident
iabetes, as well as diagnosed diabetes mellitus on cardiovascular
vents after a mean follow-up duration of 7.5 years, and its
onclusion of IFG not being independently associated with an
ncreased short-term risk for incident cardiovascular events
whereas diabetes mellitus type 2 was). The well-written paper
ttempts to answer a pertinent debate on whether IFG is an
ndependent risk factor for incident cardiovascular events—the
ata thus far has been variable and heterogeneous (2,3). However,
few interesting points arise from the analysis, which we feel, mayequire clarification.
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worsening glucose control in nondiabetic patients and its effects on
development of chronic kidney disease. With the well-established
role of chronic kidney disease, especially in dysglycemic patients
(5), it would be interesting to know if the investigators made any
attempts to look at the renal functions of the patients and made
any attempts to adjust for the same.
Second, it would also be interesting to know if the investigators
had data on levels of glycosylated hemoglobin (Hb) A1c for the
patients with IFG, and if any attempts were made to correlate the
same with events, as HbA1c has been indicated to better reflect
glycemic status even for IFG patients (6,7).
Third, it would be interesting to know the thoughts of the
investigators regarding the fact that addition of body mass index
only (Fig. 3, Model 3) (1), to the Model 2 (1) multivariable
analysis, changed the outcomes of the study from a statistically
significant one to one that is not.
The role of IFG in de novo cardiovascular events is a fascinating
topic, and we thank Dr. Yeboah and colleagues for shedding light
on interesting facets of the same.
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Reply
We thank Drs. Chatterjee and Maitra for their interest in our
paper regarding impaired fasting glucose and the risk of incident
diabetes mellitus and cardiovascular events in MESA (Multi-
Ethnic Study of Atherosclerosis) (1).
The first question raised was based on the paper by Fox et al. (2)
n glycemic control and development of kidney disease in the
ramingham Heart Study. Individuals with chronic kidney diseaseCKD) have an increased cardiovascular risk, but the relevance ofkidney function in statistical models depends on the cohort under
consideration and the question being asked. Covariates adjusted
for in our models were selected based on evidence of associations
in our univariate analysis and on prior publications. The MESA
cohort by design included relatively healthy individuals with a low
prevalence of CKD. Adding a measure of kidney disease (serum
creatinine, estimated glomerular filtration rate, or cystatin C levels)
did not change either the point estimates or the confidence
intervals of risk estimates reported in our paper.
The authors completely agree with regards to the second question
raised. Indeed, it would have been very interesting if data on
hemoglobin A1c were also provided. Unfortunately even though data
on hemoglobin A1c is available in MESA, it was measured during the
second MESA visit, whereas fasting blood glucose levels used in the
analysis to define participants as having normoglycemia, impaired
fasting glucose, or diabetes mellitus were measured during the
baseline examination (1). We believe that answering the same
question using samples from periods separated by years would yield
inaccurate results and would lead to inaccurate inferences.
Finally, the addition of body mass index to the stepwise Cox
proportional hazard model that included age, sex, and race/ethnicity
attenuated the univariate association between impaired fasting glucose
and incident cardiovascular events in MESA. This is not surprising
given the strong association between body mass index and glucose.
Thus, the apparent association between impaired fasting glucose and
incident cardiovascular events in our univariate analysis could be
explained by a combination of the variance in age, sex, race/ethnicity,
and the body mass index of the subcohort.
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Determinants of Exercise
Intolerance in Heart Failure
With Preserved Ejection Fraction
The article by Haykowsky et al. (1) is a comprehensive examina-
tion of contributors to the reduced exercise capacity universally
